![Stephen G. Sudovar](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen G. Sudovar
Director Ejecutivo en SGS Associates .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Rodger DeRose | M | - |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
Robert Zerbe | M | 73 | 18 años | |
Anne E. Ammons | F | - |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
Glenn M. Reiter | M | - |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
Michael A. Saffer | M | - |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
Alan Rubino | M | 69 | 19 años | |
Ralph LaRossa | M | 61 |
Montclair State University
| - |
Saverio Garruto | M | 75 |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
C. William Weisser | M | - |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
Judith Schumacher-Tilton | F | - |
Montclair State University
| - |
Ellen Salsburg | F | - |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
Alyce C. Halchak | F | - |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
Mary Rose Migliazza | F | - |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
M. John Germain | M | - |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
Sam Garruto | M | - |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
Janice M. Beauchamp | F | - |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
Diane Zezza | F | - |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
Lisa Peterson | F | - |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
Bruce Schnelwar | M | - |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
Guy Tufo | M | - |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
Mitchell E. Hersh | M | 73 |
Montclair State University
| - |
Carol Blazejowski | F | - |
Montclair State University
| - |
Doug Kennedy | M | 67 |
Montclair State University
| - |
Laurence Aronson | M | 67 |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
John G. Garett | M | - |
Montclair State University
| - |
David Schonbraun | M | 45 |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
Robert Herz | M | 70 |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
Matt Mustachio | M | - |
Montclair State University
| - |
Michael L. Rodburg | M | - |
Montclair State University
| - |
Dennis M. Bone | M | 72 |
Montclair State University
| - |
Dean Janeway | M | 80 |
Kessler Foundation Inc
![]() Kessler Foundation Inc Personnel ServicesCommercial Services Kessler Foundation, Inc. provides public charity and rehabilitation services. It helps the people with physical and cognitive disabilities caused by stroke, multiple sclerosis, brain and spinal cord injury, and other chronic neurologic and musculoskeletal conditions. The company is headquartered in West Orange, NJ. | - |
Elizabeth Posillico | M | - |
Elusys Therapeutics, Inc.
![]() Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | 22 años |
Preston Pinkett | M | - |
Montclair State University
| - |
Francis Cuss | M | 70 |
Montclair State University
| - |
Michael Capone | M | 57 |
Montclair State University
| - |
Frederick Schmid | M | 67 |
Roche Laboratories, Inc.
![]() Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | 27 años |
Susan Blount | F | 66 |
Montclair State University
| - |
Andrew Mees | M | - |
Montclair State University
| - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
R. Douglas Armstrong | M | 70 | 19 años | |
Gerald D. Brennan | M | 73 | 4 años | |
Raafat E. F. Fahim | M | 70 |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | 9 años |
Jordan I. Siegel | M | 58 |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | 2 años |
Nelson M. Sims | M | 76 | 9 años | |
Thomas McLain | M | 66 |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | 9 años |
David J. Gury | M | 85 |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | 20 años |
Linda L. Nardone | M | 77 |
Elusys Therapeutics, Inc.
![]() Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | 6 años |
Jason Aryeh | M | 55 |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | 6 años |
Peter B. Davis | M | 77 |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | 6 años |
Adam Logal | M | 46 |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | 5 años |
Mark L. Smith | M | 72 |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | 7 años |
Paul Kessler | M | 69 |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | 7 años |
George Elston | M | 59 |
Elusys Therapeutics, Inc.
![]() Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | - |
George Dunbar | M | 77 | 4 años | |
Timothy Patrick Lynch | M | 54 |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | 5 años |
Matthew Kalnik | M | 61 |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | 5 años |
James Andrew Cour | M | 68 | 2 años | |
Tod Borton | M | - | - | |
Frédéric Porte | M | - |
Ambrilia Biopharma, Inc.
![]() Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | - |
Sheldon A. Schaffer | M | - | - | |
Stephen E. Lawton | M | - |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | - |
Elmar R. Burchardt | M | - | 4 años | |
Christine V. Sapan | M | 76 |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | - |
Peter C. Alain | M | - | - | |
Sherrill M. MacKay | F | - | - | |
Frances J. Kivel | F | - | - | |
Jack Maroney | M | - |
Roche Laboratories, Inc.
![]() Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | 2 años |
Thomas E. Rathjen | M | - |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | - |
Arthur F. Staubitz | M | - | 6 años | |
Bernard Coupal | M | - |
Ambrilia Biopharma, Inc.
![]() Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | 8 años |
Leslie Hudson | M | 76 |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | - |
George W. Ebright | M | 85 |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | - |
Patrick Zenner | M | 77 |
Roche Laboratories, Inc.
![]() Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | 24 años |
Myron Holubiak | M | 77 |
Roche Laboratories, Inc.
![]() Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | 3 años |
Linda Manoogian Fingerle | F | - | 1 años | |
Joseph J. Krivulka | M | 73 |
Ambrilia Biopharma, Inc.
![]() Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | 1 años |
Daniel E. Greenleaf | M | 59 |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | 1 años |
Roberto Pedro Rosenkranz | M | 74 |
Roche Laboratories, Inc.
![]() Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | 2 años |
Hans J. Mäder | M | - |
Ambrilia Biopharma, Inc.
![]() Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | - |
Linda S. Jenckes | F | 76 |
Nabi Biopharmaceuticals
![]() Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | 13 años |
Ronnda L. Bartel | M | 65 | 7 años | |
Luc Tanguay | M | 65 |
Ambrilia Biopharma, Inc.
![]() Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | 4 años |
David Stack | M | 72 |
Roche Laboratories, Inc.
![]() Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | 12 años |
Max E. Link | M | 84 |
Ambrilia Biopharma, Inc.
![]() Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | - |
Joseph A. Taylor | M | - | 7 años | |
Jeani Delagardelle | F | 67 |
Roche Laboratories, Inc.
![]() Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | 1 años |
George Harb | M | - |
Roche Laboratories, Inc.
![]() Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | - |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 80 | 93.02% |
Canadá | 6 | 6.98% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Stephen G. Sudovar
- Red Personal